Navigation Links
Chimerix Files Registration Statement for Proposed Initial Public Offering
Date:3/8/2013

>Chimerix is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need. The Company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. 

Chimerix's lead product candidate, CMX001, is a broad spectrum, oral nucleotide analog lipid-conjugate that blocks replication of double-stranded DNA (dsDNA) viruses, including cytomegalovirus (CMV), adenovirus (AdV), BK virus and herpes simplex virus.  CMX001 has completed Phase 2 clinical development for the prevention of CMV in hematopoietic stem cell transplant (HSCT) recipients.  Chimerix is also conducting a Phase 2 study in HSCT recipients which is evaluating CMX001 as a preemptive therapy for AdV disease, an often-fatal infection which has no approved therapies.  Since 2009, Chimerix has made CMX001 available under expanded access regulations to over 80 transplant centers worldwide for the treatment of over 430 patients with life-threatening dsDNA viral infections.  Chimerix anticipates initiating SUPPRESS, its Phase 3 study of CMX001 for the prevention of CMV infection in adults undergoing HSCT, in 2013.   

Chimerix is also developing CMX001 as a potential medical countermeasure against smallpox under a contract from the Biomedical Advanced Research and Development Authority (BARDA). 

Chimerix's second product candidate, CMX157, an oral nucleotide analog lipid-conjugate in Phase 1 development for the treatment of HIV infection, was licensed to Merck in July 2012.   


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
4. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
5. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
6. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
7. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
8. Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2012
9. AUL Files Seventh Brief Supporting First Amendment Freedom of Conscience
10. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
11. Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- The Galien Foundation today announced the 2014 nominees ... Awards. The Prix Galien Award is considered ... scientific and clinical research skills necessary to develop innovative ... highest number of nominees since the inception of the ... biomedical products across three categories – biotechnology, pharmaceutical, and ...
(Date:7/31/2014)... , July 31, 2014  Today, ... a new extension to its PageCenterX ® ... software is designed to provide downtime reporting capabilities ... outages. LRS is releasing the product for general ... environment, EMR applications experience outages for a variety ...
(Date:7/31/2014)... July 31, 2014 Cryoport, Inc. (OTCBB: CYRX) ... ended June 30, 2014. Recent Operating ... million for the three month period ended June 30, ... Partnered with DHL to further expand Cryoport,s global reach ... , Advanced support of Immudex, an immunotherapy and vaccine ...
Breaking Medicine Technology:The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5LRS Announces Downtime Reporting Solution for Healthcare 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8
(Date:7/31/2014)... July 31, 2014 RankingBySEO, a prominent ... those individuals and organizations against whom negative reviews are ... Negative Comments Service’. , About the service, a ... officially announced the service now, but we have been ... negative comments for several years.” , On being asked ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Rivetz Corp. ... generation authentication services to cloud service providers. The combined ... hardware protected multi-factor authentication with online systems. , ... on password-based authentication. It is the root cause of ... place around the globe. Instead of solving the problem, ...
(Date:7/31/2014)... July 31, 2014 Thousands of ... across the country have come together today to ... Pharmacy’s annual tradeshow. , "ThoughtSpot 2014 is Good ... resources and tools to help their businesses thrive," ... “We have a long-standing commitment to independent community ...
(Date:7/31/2014)... FITNESS SF, a growing chain of health ... upgrade all locations to Motionsoft’s full cloud-based ... is a leading provider of club management solutions, and ... payments services for health and wellness centers. MoSo is ... SF bundled with the MoSo Pay secure billing solution ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The Beryl ... Experience Executive Board and four new members of ... its role as the global community of practice and ... healthcare. , Executive board members are industry leaders ... and provide valuable insight into market and industry trends. ...
Breaking Medicine News(10 mins):Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:FITNESS SF Upgrades Motionsoft Software to Include Entire Product Lineup: MoSo + MoSo Pay + MyClub 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3
... of Infection Control and Hospital Epidemiology finds that ... Staphylococcus aureus (MRSA), and suggests that some nursing homes ... bacteria, which can lead to hard-to-treat infections. The study, ... found that 31 percent of the residents who were tested ...
... Mozes HealthDay Reporter , WEDNESDAY, Dec. 1 (HealthDay ... of radiation exposure from CT scans may be lower than ... to be presented Wednesday at the annual meeting of the ... an eight-year analysis of Medicare records covering nearly 11 million ...
... , WEDNESDAY, Dec. 1 (HealthDay News) -- Deployment to ... of sleep of many U.S. military personnel, new research ... members of the U.S. military before they deployed to ... Dec. 1 issue of the journal Sleep . ...
... , Glucocorticoid drugs are used widely to ... and some forms of cancer, and transplant recipients. The ... and immunosuppressive properties. However, their long-term use is limited ... glucose, fatty liver, and type 2 diabetes. A team ...
... Researchers from Boston University School of Medicine (BUSM) have ... agents can enter and kill cancer cells. This finding, which ... Journal of Virology , could help lead to the development ... The study was conducted by Ewan F. Dunn, a postdoctoral ...
... in French . Montreal, December 1st, 2010 ... more closely connected than previously imagined. The damaging effects of ... also affect the brain. In fact, infarction seems to cause ... to insomnia, notably paradoxical insomnia. Sleep plays a crucial role ...
Cached Medicine News:Health News:MRSA carriage rates vary widely in nursing homes, study finds 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 3Health News:Military Deployment May Lead to Unhealthy Sleep Patterns 2Health News:JCI online early table of contents: Dec. 1, 2010 2Health News:JCI online early table of contents: Dec. 1, 2010 3Health News:JCI online early table of contents: Dec. 1, 2010 4Health News:JCI online early table of contents: Dec. 1, 2010 5Health News:JCI online early table of contents: Dec. 1, 2010 6Health News:JCI online early table of contents: Dec. 1, 2010 7Health News:JCI online early table of contents: Dec. 1, 2010 8Health News:JCI online early table of contents: Dec. 1, 2010 9Health News:JCI online early table of contents: Dec. 1, 2010 10Health News:Insomnia after myocardial infarction 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: